How Does Thermo Fisher Scientific Make its Money?
Thermo Fisher Scientific is the world’s largest life sciences company by revenue, serving research labs, hospitals, pharmaceutical companies, and governments worldwide. The company provides scientific instruments, reagents, consumables, software, and services used in healthcare, life science research, and industrial applications. Thermo Fisher built its dominant position through a series of transformative acquisitions, including Life Technologies and Patheon, making it a one-stop shop for scientists and biopharmaceutical companies.
Thermo Fisher Scientific (TMO) Business Model
Thermo Fisher Scientific operates in the life sciences sector. Below is a summary of Thermo Fisher Scientific’s revenue streams, how the company generates income, and the key financial metrics from its most recent annual report. This breakdown uses data from Thermo Fisher Scientific’s 2024 fiscal year filings with the SEC.
Thermo Fisher Scientific Competitors
Thermo Fisher Scientific’s key competitors and comparable public companies in the life sciences sector include Danaher, Abbott Laboratories, and Eli Lilly. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Thermo Fisher Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Thermo Fisher Scientific Competitors
Thermo Fisher Scientific’s key competitors and comparable public companies in the life sciences sector include Danaher, Abbott Laboratories, and Eli Lilly. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Thermo Fisher Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Thermo Fisher Scientific Competitors
Thermo Fisher Scientific’s key competitors and comparable public companies in the life sciences sector include Danaher, Abbott Laboratories, and Eli Lilly. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Thermo Fisher Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Thermo Fisher Scientific Competitors
Thermo Fisher Scientific’s key competitors and comparable public companies in the life sciences sector include Danaher, Abbott Laboratories, and Eli Lilly. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Thermo Fisher Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Thermo Fisher Scientific Competitors
Thermo Fisher Scientific’s key competitors and comparable public companies in the life sciences sector include Danaher, Abbott Laboratories, and Eli Lilly. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Thermo Fisher Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Thermo Fisher Scientific Competitors
Thermo Fisher Scientific’s key competitors and comparable public companies in the life sciences sector include Danaher, Abbott Laboratories, and Eli Lilly. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Thermo Fisher Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Thermo Fisher Scientific Competitors
Thermo Fisher Scientific’s key competitors and comparable public companies in the life sciences sector include Danaher, Abbott Laboratories, and Eli Lilly. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Thermo Fisher Scientific stacks up by comparing their revenue breakdown, margins, and growth metrics.
Revenue Breakdown
| Segment | 2024 | 2023 | YoY Growth |
|---|---|---|---|
| Laboratory Products & Biopharma Services | $20,400 | $20,200 | +1.0% |
| Life Sciences Solutions | $10,700 | $10,200 | +4.9% |
| Analytical Instruments | $7,300 | $7,100 | +2.8% |
| Specialty Diagnostics | $4,500 | $4,400 | +2.3% |
| Total Revenue | $42,900 | $42,900 | +0.0% |
Laboratory Products & Biopharma Services — 48% of Revenue
Life Sciences Solutions — 25% of Revenue
Analytical Instruments — 17% of Revenue
Specialty Diagnostics — 10% of Revenue
Income Statement Overview
| Metric | 2024 | 2023 |
|---|---|---|
| Total Revenue | $42,900 | $42,900 |
| Cost of Revenue | $25,200 | $25,300 |
| Gross Profit | $17,700 | $17,600 |
| Operating Expenses | $9,200 | $9,100 |
| Operating Income | $8,500 | $8,500 |
| Net Income | $6,000 | $5,900 |
All values in millions USD unless otherwise stated.
Key Financial Metrics
- Gross Margin: 41.3%
- Operating Margin: 19.8%
- Revenue Growth: 0.0%
Is Thermo Fisher Scientific Profitable?
Yes, Thermo Fisher Scientific is profitable. The company reported net income of $6,000 on total revenue of $42,900. With an operating margin of 19.8%, Thermo Fisher Scientific demonstrates solid profitability for the life sciences sector. The gross margin of 41.3% reflects Thermo Fisher Scientific’s pricing power and cost structure.
What to Watch
- Recovery in biotech and pharma customer spending after 2023-2024 destocking
- Growth of the biopharma services business from increased outsourcing trends
- Impact of US government spending changes on research funding
- Bolt-on acquisitions to expand capabilities in high-growth segments
Thermo Fisher Scientific (TMO) Financial Summary
Thermo Fisher Scientific (TMO) is a life sciences company that generated $42,900 in total revenue in fiscal year 2024. Revenue grew 0.0% year-over-year. The company earned $6,000 in net income, making it profitable. For a deeper look at Thermo Fisher Scientific’s revenue breakdown, business segments, and financial performance, review the detailed analysis above.